Conditions: Cancer
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 37
Healthy volunteers: no

Brief summary:
A phase 1 dose-escalation trial to assess the safety, tolerability, and pharmacodynamics of PF-04691502 in adult cancer patients with solid tumors.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: PF-04691502
Intervention descriptions: intervention 1: Once daily continuous dosing. Dose escalation to Maximally tolerated dose (MTD) until progression or discontinuation.

Protocol document: